Literature DB >> 9234818

Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells.

T Krakauer1, B Fleischer, D L Stevens, B A McClane, B G Stiles.   

Abstract

We investigated the potential superantigenic properties of Clostridium perfringens enterotoxin (CPE) on human peripheral blood mononuclear cells (PBMC). In contrast to the findings of a previous report (P. Bowness, P. A. H. Moss, H. Tranter, J. I. Bell, and A. J. McMichael, J. Exp. Med. 176:893-896, 1992), two different, biologically active preparations of CPE had no mitogenic effects on PBMC. Furthermore, PBMC incubated with various concentrations of CPE did not elicit interleukin-1, interleukin-2, gamma interferon, or tumor necrosis factor alpha or beta, which are cytokines commonly associated with superantigenic stimulation. However, CPE did cause a dose-related release of interleukin-6 from PBMC cultures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234818      PMCID: PMC175495          DOI: 10.1128/iai.65.8.3485-3488.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.

Authors:  T Uchiyama; Y Kamagata; X J Yan; A Kawachi; H Fujikawa; H Igarashi; M Okubo
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  Production, purification, and assay of Clostridium perfringens enterotoxin.

Authors:  J L McDonel; B A McClane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.

Authors:  B Fleischer; R Gerardy-Schahn; B Metzroth; S Carrel; D Gerlach; W Köhler
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

4.  Myoelectric activity in the small intestine in response to Clostridium perfringens A enterotoxin: correlation with histologic findings in an in vivo rabbit model.

Authors:  P G Justus; J R Mathias; J L Martin; G M Carlson; R P Shields; S B Formal
Journal:  Gastroenterology       Date:  1981-05       Impact factor: 22.682

5.  Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.

Authors:  M A Woody; T Krakauer; B G Stiles
Journal:  Vaccine       Date:  1997-02       Impact factor: 3.641

6.  Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.

Authors:  R S Kornbluth; T S Edgington
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

7.  Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.

Authors:  V V Micusan; G Mercier; A R Bhatti; R F Reiser; M S Bergdoll; D Oth
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

8.  T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures.

Authors:  B Fleischer; H Schrezenmeier; P Conradt
Journal:  Cell Immunol       Date:  1989-04-15       Impact factor: 4.868

9.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Authors:  A Waage; P Brandtzaeg; A Halstensen; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Authors:  C Jupin; S Anderson; C Damais; J E Alouf; M Parant
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.

Authors:  Leslie A Mitchell; Michael Koval
Journal:  Toxins (Basel)       Date:  2010-06-24       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.